Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Administered as Single Bolus Injections or Infusions in Japanese Subjects With Iron Deficiency Anemia

NCT03013439 is registered in ClinicalTrials.gov with Pharmacosmos A/S as lead sponsor.

NCT NCT03013439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03013439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Administered as Single Bolus Injections or Infusions in Japanese Subjects With Iron Deficiency Anemia
Lead sponsor
Pharmacosmos A/S
Phase
Phase 1
Overall status
Completed
Start date
January 6, 2017
Completion date
June 4, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, anemia, iron deficiency, deficiency diseases, hematologic disease, iron metabolism disorders